← Product Code [LNH](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LNH) · K023686 # AURORA MR-GUIDED INTERVENTIONAL SYSTEM (K023686) _Aurora Imaging Technology, Inc. · LNH · Jan 29, 2003 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LNH/K023686 ## Device Facts - **Applicant:** Aurora Imaging Technology, Inc. - **Product Code:** [LNH](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LNH.md) - **Decision Date:** Jan 29, 2003 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.1000 - **Device Class:** Class 2 - **Review Panel:** Radiology ## Intended Use The Aurora® MR-Guided Interventional System (the System) is an optional accessory to the Aurora Imaging Technology, Inc., Magnetic Resonance Diagnostic Device. The System is intended to aid in the performance of minimally invasive diagnostic procedures of the lateral or medial side of either breast and adjacent anatomies, which may be facilitated by MR guidance. Such procedures must be performed with MR-compatible devices as selected and evaluated by the clinical user. ## Device Story System acts as accessory to Aurora MR diagnostic device; facilitates minimally invasive breast diagnostic procedures. Inputs: MR images. Operation: 3D MR-visible crosshair mounted near needle guide; stage moves to target lesion based on MR image coordinates. Subsystems: base plate, needle guidance stage, position display unit (PDU), target planning software. Used in clinical setting by physicians. Output: needle guidance positioning. Benefit: enables precise MR-guided lesion localization. ## Clinical Evidence Bench testing only. Included biocompatibility testing, reprocessing validation, and verification/validation testing to demonstrate compliance with design and performance specifications. ## Technological Characteristics Accessory to MR diagnostic device; includes base plate, needle guidance stage, position display unit, and target planning software. Features 3D MR-visible crosshair for targeting. Enables 3-axis movement of needle guidance stage. MR-compatible materials. ## Regulatory Identification A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information). ## Special Controls *Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. ## Predicate Devices - MRI Devices Breast Immobilization and Biopsy Device MR-Biopsy 160 ([K010570](/device/K010570.md)) - Philips Stereotactic Localization Device ([K000832](/device/K000832.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K62 3686 JAN 2 9 2003 # 510(k) Summary Aurora Imaging Technology, Inc. Aurora® MR-Guided Interventional System ## SPONSOR 1. Aurora Imaging Technology, Inc. 39 High Street North Andover, MA 01845 Contact Person: Alan Oslan Telephone: 987-975-7530, Ext. 4326 Date Prepared: October 31, 2002 #### 2. DEVICE NAME Proprietary Name: Common/Usual Name: Classification Name: Aurora® MR-Guided Interventional System MR-Guided lesion localization system Accessory to a magnetic resonance device ### 3. PREDICATE DEVICES - MRI Devices Breast Immobilization and Biopsy Device MR-Biopsy 160 ● (K010570) - Philips Stereotactic Localization Device (K000832) ● ### 4. DEVICE DESCRIPTION The use and operation of the Aurora® MR-Guided Interventional System and other MR-guided biopsy systems is based on the well-known method of target planning to determine the desired placement of an interventional device in three dimensions from an MR image. The basic targeting technique uses a three-dimensional MR-visible crosshair mounted near the needle guide in a fixed and known location. The stage is moved so that the needle guide and, consequently, the marker are moved to the general vicinity of the lesion to be targeted. The Aurora® MR-Guided Interventional System consists of four major subsystems: (1) Base plate system and components, (2) Needle guidance stage and components, (3) Position display unit (PDU), and (4) Target Planning Application (software). {1}------------------------------------------------ #### ર. INTENDED USE The Aurora® MR-Guided Interventional System (the System) is an optional accessory to the Aurora Imaging Technology, Inc., Magnetic Resonance Diagnostic Device. The System is intended to aid in the performance of minimally invasive diagnostic procedures of the lateral or medial side of either breast and adjacent anatomies, which may be facilitated by MR guidance. Such procedures must be performed with MR-compatible devices as selected and evaluated by the clinical user. ### TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE 6. The Aurora® MR-Guided Interventional System is substantially equivalent to cited predicate devices in intended use, indications for use, design, and operation. The major difference between the Aurora® System and cited predicates is the ability to move the needle guidance stage in three directions. #### 7. PERFORMANCE TESTING The Aurora® MR-Guided Interventional System was tested to and demonstrated in compliance with design and performance specifications and included biocompatibility testing, reprocessing validation, and verification/validation testing. October 31, 2002 Page G-2 {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three wavy lines representing its wings. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Alan Oslan Program Manager, Interventional Systems Aurora Imaging Technology 39 High Street NORTH ANDOVER MA 01845 Re: K023686 Trade/Device Name: Aurora® MR-Guided Interventional System Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: 90 LNH Dated: October 31, 2002 Received: November 1, 2002 Dear Mr. Oslan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include reguirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. JAN 2 9 2003 {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 8xx.1xxx | (301) 594-4591 | |----------------------------------|----------------| | 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 | | 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 | | 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 | | Other | (301) 594-4692 | Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): Device Name: Aurora® MR-Guided Interventional System Indications for Use: The Aurora® MR-Guided Interventional System (the System) is an optional accessory to the Aurora Imaging Technology, Inc., Magnetic Resonance Diagnostic Device. The System is intended to aid in the performance of minimally invasive diagnostic procedures of the lateral or medial side of either breast and adjacent anatomies, which may be facilitated by MR guidance. Such procedures must be performed with MR-compatible devices as selected and evaluated by the clinician. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY) Concurrence of CDRH, Office of Device Evaluation (ODE) David A. Seymm Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) Aurora Imaging Technology, Inc., Traditional 510(k) Aurora® MR-Guided Interventional System October 31, 2002 Page vii --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LNH/K023686](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LNH/K023686) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com